Navidea Biopharma signs first Asian distribution agreement

Navidea Biopharmaceuticals (NAVB) announces a distribution agreement with
Global Medical Solutions Taiwan for Lymphoseek.

NAVB says the deal builds "on the growth of Lymphoseek sales in the United States, which continue the positive trends recently reported."

The company says it will work with its partner to address Taiwanese regulatory requirements and expects "local approval in 2014-15," although Lymphoseek may be available prior to approval "in appropriate situations." (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs